CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 665598-665843 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"These findings are consistent with other studies showing that, in comparison to CRSsNP, CRScNP tends to be more difficult to treat and have a higher rate of relapse after intensive medical therapy (Subramanian et al, Am J Rhinology 2002;16:303).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T87345","span":{"begin":0,"end":245},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T87345","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T1106","span":{"begin":0,"end":245},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T1106","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T301","span":{"begin":0,"end":245},"obj":"Sentence"}],"attributes":[{"subj":"T301","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecb393","default":true},{"id":"Epistemic_Statements","color":"#9993ec"},{"id":"CORD-19_Custom_license_subset","color":"#a6ec93"}]}]}}